P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia

Journal of Neurochemistry

Volumn 122, Issue 5, 2012, Pages 962-975

  McCaffrey, Gwen ^a   Staatz, William D ^a   Sanchez Covarrubias, Lucy ^a   Finch, Jessica D ^a   Demarco, Kristen ^a   Laracuente, Mei Li ^a   Ronaldson, Patrick T ^a   Davis, Thomas P ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

blood brain barrier; caveolin; inflammatory pain; P glycoprotein; protein trafficking

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANALGESIC AGENT; CARRAGEENAN; CAVEOLIN 1; DISULFIDE; GLYCOPROTEIN P; SCAFFOLD PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL FRACTIONATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISULFIDE BOND; DRUG TRANSPORT; ENZYME ACTIVITY; FEMALE; HYPERALGESIA; INFLAMMATORY PAIN; MEMBRANE TRANSPORT; MICROVASCULATURE; MOLECULAR WEIGHT; NONHUMAN; PERIPHERAL INFLAMMATORY HYPERALGESIA; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; RAT; VASCULAR ENDOTHELIUM;

ADENOSINE TRIPHOSPHATASES; ANIMALS; BLOOD-BRAIN BARRIER; CARRAGEENAN; CAVEOLIN 1; DISEASE MODELS, ANIMAL; FEMALE; HYPERALGESIA; MICROVESSELS; MOLECULAR WEIGHT; NEUROGENIC INFLAMMATION; P-GLYCOPROTEIN; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84865346007     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07831.x     Document Type: Article

References (68)

1. Abbott N. J., Patabendige A. A., Dolman D. E., Yusof S. R., and, Begley D. J., (2010) Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25.
2. Barakat S., Gayet L., Dayan G., Labialle S., Lazar A., Oleinikov V., Coleman A. W., and, Baggetto L. G., (2005) Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis. Biochem. J. 388, 563-571. (Pubitemid 40839934)
3. Barakat S., Demeule M., Pilorget A., Regina A., Gingras D., Baggetto L. G., and, Beliveau R., (2007) Modulation of p-glycoprotein function by caveolin-1 phosphorylation. J. Neurochem. 101, 1-8. (Pubitemid 46426486)
4. Barakat S., Turcotte S., Demeule M., Lachambre M. P., Regina A., Baggetto L. G., and, Beliveau R., (2008) Regulation of brain endothelial cells migration and angiogenesis by P-glycoprotein/caveolin-1 interaction. Biochem. Biophys. Res. Commun. 372, 440-446.
5. Bartels A. L., (2011) Blood-brain barrier p-glycoprotein function in neurodegenerative disease. Curr. Pharm. Des. 17, 2771-2777.
6. Bauer B., Hartz A. M., Fricker G., and, Miller D. S., (2005) Modulation of p-glycoprotein transport function at the blood-brain barrier. Exp. Biol. Med. (Maywood) 230, 118-127.
7. Beaulieu E., Demeule M., Ghitescu L., and, Beliveau R., (1997) P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain. Biochem. J. 326, 539-544. (Pubitemid 27417234)
8. Bendayan R., Ronaldson P. T., Gingras D., and, Bendayan M., (2006) In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J. Histochem. Cytochem. 54, 1159-1167. (Pubitemid 44434719)
9. Bolte S., and, Cordelieres F. P., (2006) A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213-232. (Pubitemid 46010930)
10. Choo E. F., Kurnik D., Muszkat M., et al. (2006) Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier. J. Pharmacol. Exp. Ther. 317, 1012-1018. (Pubitemid 43764103)
11. Cordon-Cardo C., O'Brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R., and, Bertino J. R., (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl Acad. Sci. USA 86, 695-698. (Pubitemid 19037807)
12. De Klerk O. L., Bosker F. J., Luurtsema G., Nolte I. M., Dierckx R., Den Boer J. A., and, Potschka H., (2011) The role of p-glycoprotein in psychiatric disorders: a reliable guard of the brain? Cent. Nerv. Syst. Agents Med. Chem. 11, 197-209.
13. Demeule M., Jodoin J., Gingras D., and, Beliveau R., (2000) P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries. FEBS Lett. 466, 219-224. (Pubitemid 30069829)
14. Fletcher J. I., Haber M., Henderson M. J., and, Norris M. D., (2010) ABC transporters in cancer: more than just drug efflux pumps. Nat. Rev. Cancer 10, 147-156.
15. Gannon M. K. II, Holt J. J., Bennett S. M., et al. (2009) Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity. J. Med. Chem. 52, 3328-3341.
16. Guo Z., Zhu J., Zhao L., Luo Q., and, Jin X., (2010) Expression and clinical significance of multidrug resistance proteins in brain tumors. J. Exp. Clin. Cancer Res. 29, 122.
17. Hargreaves K., Dubner R., Brown F., Flores C., and, Joris J., (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77-88.
18. Hartz A. M., and, Bauer B., (2010) Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy. Mol. Interv. 10, 293-304.
19. Hawkins B. T., and, Davis T. P., (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57, 173-185. (Pubitemid 41043883)
20. Hawkins B. T., Rigor R. R., and, Miller D. S., (2010) Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay. J. Cereb. Blood Flow Metab. 30, 1593-1597.
21. Huber J. D., Hau V. S., Borg L., Campos C. R., Egleton R. D., and, Davis T. P., (2002) Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 283, H1531-H1537.
22. Ibuki T., Matsumura K., Yamazaki Y., Nozaki T., Tanaka Y., and, Kobayashi S., (2003) Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J. Neurochem. 86, 318-328. (Pubitemid 36842431)
23. Jodoin J., Demeule M., Fenart L., Cecchelli R., Farmer S., Linton K. J., Higgins C. F., and, Beliveau R., (2003) P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. J. Neurochem. 87, 1010-1023. (Pubitemid 37444575)
24. Juliano R. L., and, Ling V., (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162.
25. Kannan P., John C., Zoghbi S. S., Halldin C., Gottesman M. M., Innis R. B., and, Hall M. D., (2009) Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin. Pharmacol. Ther. 86, 368-377.
26. Kaye S. B., (2008) Reversal of drug resistance in ovarian cancer: where do we go from here? J. Clin. Oncol. 26, 2616-2618.
27. Lajoie P., Goetz J. G., Dennis J. W., and, Nabi I. R., (2009) Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J. Cell Biol. 185, 381-385.
28. Leggas M., Adachi M., Scheffer G. L., et al. (2004) Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell. Biol. 24, 7612-7621. (Pubitemid 39121487)
29. Lespine A., Martin S., Dupuy J., Roulet A., Pineau T., Orlowski S., and, Alvinerie M., (2007) Interaction of macrocyclic lactones with P-glycoprotein: structure-affinity relationship. Eur. J. Pharm. Sci. 30, 84-94. (Pubitemid 44908930)
30. Lochhead J. J., McCaffrey G., Quigley C. E., Finch J., DeMarco K. M., Nametz N., and, Davis T. P., (2010) Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 30, 1625-1636.
31. Loo T. W., and, Clarke D. M., (1996) The minimum functional unit of human P-glycoprotein appears to be a monomer. J. Biol. Chem. 271, 27488-27492. (Pubitemid 26367310)
32. Loo T. W., and, Clarke D. M., (2000) Drug-stimulated ATPase activity of human P-glycoprotein is blocked by disulfide cross-linking between the nucleotide-binding sites. J. Biol. Chem. 275, 19435-19438. (Pubitemid 30441531)
33. Loo T. W., Bartlett M. C., and, Clarke D. M., (2010) Human P-glycoprotein is active when the two halves are clamped together in the closed conformation. Biochem. Biophys. Res. Commun. 395, 436-440.
34. Macdonald J. L., and, Pike L. J., (2005) A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res. 46, 1061-1067.
35. McCaffrey G., Staatz W. D., Quigley C. A., Nametz N., Seelbach M. J., Campos C. R., Brooks T. A., Egleton R. D., and, Davis T. P., (2007) Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J. Neurochem. 103, 2540-2555.
36. McCaffrey G., Seelbach M. J., Staatz W. D., Nametz N., Quigley C., Campos C. R., Brooks T. A., and, Davis T. P., (2008) Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia. J. Neurochem. 106, 2395-2409.
37. McCaffrey G., Willis C. L., Staatz W. D., Nametz N., Quigley C. A., Hom S., Lochhead J. J., and, Davis T. P., (2009) Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. J. Neurochem. 110, 58-71.
38. Miller D. S., (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol. Sci. 31, 246-254.
39. Miller D. S., Bauer B., and, Hartz A. M., (2008) Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol. Rev. 60, 196-209. (Pubitemid 351962009)
40. Muller C., Laurent G., and, Ling V., (1995) P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J. Cell. Physiol. 163, 538-544.
41. Nies A. T., Jedlitschky G., Konig J., Herold-Mende C., Steiner H. H., Schmitt H. P., and, Keppler D., (2004) Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129, 349-360. (Pubitemid 39388854)
42. Pan W., Yu C., Hsuchou H., and, Kastin A. J., (2010) The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors. Cell. Physiol. Biochem. 25, 623-630.
43. Pardridge W. M., (2007) Drug targeting to the brain. Pharm. Res. 24, 1733-1744. (Pubitemid 47206623)
44. Poller B., Drewe J., Krahenbuhl S., Huwyler J., and, Gutmann H., (2010) Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell. Mol. Neurobiol. 30, 63-70.
45. Poruchynsky M. S., and, Ling V., (1994) Detection of oligomeric and monomeric forms of P-glycoprotein in multidrug resistant cells. Biochemistry 33, 4163-4174. (Pubitemid 24140600)
46. Potschka H., (2010a) Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies? Epilepsia 51, 1333-1347.
47. Potschka H., (2010b) Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. Pharmacol. Ther. 125, 118-127.
48. del Pozo M. A., Balasubramanian N., Alderson N. B., Kiosses W. B., Grande-Garcia A., Anderson R. G., and, Schwartz M. A., (2005) Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat. Cell Biol. 7, 901-908. (Pubitemid 41486291)
49. Reese T. S., and, Karnovsky M. J., (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34, 207-217.
50. Roberts D. J., and, Goralski K. B., (2008) A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin. Drug Metab. Toxicol. 4, 1245-1264.
51. Robertson S. J., Kania K. D., Hladky S. B., and, Barrand M. A., (2009) P-glycoprotein expression in immortalised rat brain endothelial cells: comparisons following exogenously applied hydrogen peroxide and after hypoxia-reoxygenation. J. Neurochem. 111, 132-141.
52. Ronaldson P. T., and, Davis T. P., (2011) Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery. Ther. Deliv. 2, 1015-1041.
53. Rudajev V., Novotny J., Hejnova L., Milligan G., and, Svoboda P., (2005) Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and Gqalpha/G11alpha protein. J. Biochem. 138, 111-125. (Pubitemid 41265361)
54. Sargiacomo M., Scherer P. E., Tang Z., Kubler E., Song K. S., Sanders M. C., and, Lisanti M. P., (1995) Oligomeric structure of caveolin: implications for caveolae membrane organization. Proc. Natl Acad. Sci. USA 92, 9407-9411.
55. Sassi Y., Lipskaia L., Vandecasteele G., et al. (2008) Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation. J. Clin. Invest. 118, 2747-2757.
56. Schinkel A. H., Smit J. J., van Tellingen O., et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502. (Pubitemid 24153990)
57. Seelbach M. J., Brooks T. A., Egleton R. D., and, Davis T. P., (2007) Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J. Neurochem. 102, 1677-1690. (Pubitemid 47256196)
58. Sharom F. J., Yu X., Lu P., et al. (1999) Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Biochem. Pharmacol. 58, 571-586. (Pubitemid 29296877)
59. Sun J., He Z. G., Cheng G., Wang S. J., Hao X. H., and, Zou M. J., (2004) Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med. Sci. Monit. 10, RA5-RA14. (Pubitemid 38176014)
60. Szakacs G., Paterson J. K., Ludwig J. A., Booth-Genthe C., and, Gottesman M. M., (2006) Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5, 219-234. (Pubitemid 43336035)
61. Ueno M., Nakagawa T., Wu B., Onodera M., Huang C. L., Kusaka T., Araki N., and, Sakamoto H., (2010) Transporters in the brain endothelial barrier. Curr. Med. Chem. 17, 1125-1138.
62. Urbatsch I. L., Gimi K., Wilke-Mounts S., Lerner-Marmarosh N., Rousseau M. E., Gros P., and, Senior A. E., (2001) Cysteines 431 and 1074 are responsible for inhibitory disulfide cross-linking between the two nucleotide-binding sites in human P-glycoprotein. J. Biol. Chem. 276, 26980-26987.
63. Vangilder R. L., Rosen C. L., Barr T. L., and, Huber J. D., (2011) Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol. Ther. 130, 239-247.
64. Virgintino D., Robertson D., Errede M., Benagiano V., Girolamo F., Maiorano E., Roncali L., and, Bertossi M., (2002) Expression of P-glycoprotein in human cerebral cortex microvessels. J. Histochem. Cytochem. 50, 1671-1676. (Pubitemid 36078133)
65. Wang J. S., Taylor R., Ruan Y., Donovan J. L., Markowitz J. S., and, Lindsay De Vane C., (2004) Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals. Neuropsychopharmacology 29, 551-557. (Pubitemid 38365932)
66. von Wedel-Parlow M., Wolte P., and, Galla H. J., (2009) Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J. Neurochem. 111, 111-118.
67. Wei N., Sun H., Wang F., and, Liu G., (2011) H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein. Cancer Chemother. Pharmacol. 67, 1017-1025.
68. Yoshimura A., Kuwazuru Y., Sumizawa T., Ikeda S., Ichikawa M., Usagawa T., and, Akiyama S., (1989) Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. Biochim. Biophys. Acta 992, 307-314. (Pubitemid 19220892)